Analyst Ratings Network logo

LON:FEVR - Fevertree Drinks Plc (FEVR.L) Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: GBX 2,131
  • Forecasted Upside: -8.70 %
  • Number of Analysts: 12
  • Breakdown:
  • 2 Sell Ratings
  • 5 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
GBX 2,334 As of 01/15/2021 05:35 PM ET
▼ -2 (-0.09%)
1 month | 3 months | 12 months
Get New Fevertree Drinks Plc (FEVR.L) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FEVR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FEVR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 2,131
▼ -8.70% Downside Potential
This price target is based on 12 analysts offering 12 month price targets for Fevertree Drinks Plc (FEVR.L) in the last 3 months. The average price target is GBX 2,131, with a high forecast of GBX 2,570 and a low forecast of GBX 1,440. The average price target represents a -8.70% upside from the last price of GBX 2,334.
Hold
The current consensus among 12 polled investment analysts is to hold stock in Fevertree Drinks Plc (FEVR.L). This rating has held steady since October 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/25/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
10/23/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
1/21/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
4/20/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
7/19/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
10/17/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
12/16/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
1/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/13/2021Jefferies Financial GroupBoost Price TargetHoldGBX 1,900 ➝ GBX 2,150
i
10/14/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellReiterated RatingNeutral
i
10/14/2020CitigroupReiterated RatingNeutral
i
9/22/2020Morgan StanleyReiterated RatingEqual Weight
i
9/22/2020Deutsche Bank AktiengesellschaftBoost Price TargetHoldGBX 1,250 ➝ GBX 1,700
i
9/15/2020BarclaysReiterated RatingOverweightGBX 2,500
i
7/28/2020Berenberg BankBoost Price TargetBuyGBX 2,250 ➝ GBX 2,350
i
7/23/2020The Goldman Sachs GroupBoost Price TargetSellGBX 1,220 ➝ GBX 1,440
i
7/16/2020JPMorgan Chase & Co.DowngradeUnderweightGBX 1,260 ➝ GBX 1,900
i
7/14/2020Liberum CapitalReiterated RatingBuy
i
7/13/2020BarclaysInitiated CoverageOverweightGBX 2,500
i
7/10/2020HSBCBoost Price TargetBuyGBX 2,090 ➝ GBX 2,550
i
7/8/2020Liberum CapitalBoost Price TargetBuyGBX 1,675 ➝ GBX 2,570
i
7/3/2020Jefferies Financial GroupBoost Price TargetHoldGBX 1,500 ➝ GBX 2,000
i
7/1/2020The Goldman Sachs GroupReiterated RatingSell
i
6/22/2020Royal Bank of CanadaUpgradeOutperformGBX 1,100 ➝ GBX 2,500
i
6/4/2020Jefferies Financial GroupReiterated RatingHoldGBX 1,500
i
6/4/2020Liberum CapitalReiterated RatingBuy
i
4/29/2020Berenberg BankLower Price TargetBuyGBX 2,900 ➝ GBX 2,250
i
4/29/2020Liberum CapitalReiterated RatingBuy
i
4/24/2020HSBCBoost Price TargetBuyGBX 1,330 ➝ GBX 1,860
i
4/23/2020CitigroupReiterated RatingNeutral
i
4/23/2020The Goldman Sachs GroupLower Price TargetSellGBX 1,210 ➝ GBX 1,180
i
4/23/2020Jefferies Financial GroupBoost Price TargetHoldGBX 1,200 ➝ GBX 1,500
i
4/23/2020JPMorgan Chase & Co.Boost Price TargetNeutralGBX 1,050 ➝ GBX 1,260
i
4/22/2020Liberum CapitalReiterated RatingBuy
i
4/15/2020Royal Bank of CanadaLower Price TargetSector PerformerGBX 1,300 ➝ GBX 1,100
i
4/2/2020Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 1,650 ➝ GBX 1,250
i
3/30/2020The Goldman Sachs GroupLower Price TargetSellGBX 1,250 ➝ GBX 1,210
i
3/30/2020Jefferies Financial GroupLower Price TargetHoldGBX 1,500 ➝ GBX 1,200
i
3/24/2020Liberum CapitalReiterated RatingBuy
i
3/20/2020HSBCUpgradeBuy
i
3/17/2020JPMorgan Chase & Co.Lower Price TargetNeutralGBX 1,500 ➝ GBX 1,050
i
3/16/2020The Goldman Sachs GroupLower Price TargetSellGBX 1,350 ➝ GBX 1,250
i
2/26/2020The Goldman Sachs GroupInitiated CoverageSellGBX 1,350
i
2/25/2020JPMorgan Chase & Co.Reiterated RatingNeutral
i
2/24/2020Liberum CapitalReiterated RatingBuy
i
1/27/2020CitigroupReiterated RatingNeutralGBX 1,650
i
1/21/2020JPMorgan Chase & Co.Lower Price TargetOverweightGBX 2,400 ➝ GBX 1,500
i
1/21/2020Royal Bank of CanadaReiterated RatingSector Performer
i
1/21/2020Jefferies Financial GroupLower Price TargetHoldGBX 2,300 ➝ GBX 1,500
i
1/21/2020Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 2,200 ➝ GBX 1,650
i
1/20/2020Royal Bank of CanadaLower Price TargetSector PerformGBX 2,200 ➝ GBX 1,300
i
1/20/2020Liberum CapitalReiterated RatingUnder Review
i
1/8/2020HSBCReiterated RatingBuy
i
1/7/2020Liberum CapitalReiterated RatingBuy
i
12/6/2019Liberum CapitalReiterated RatingBuy
i
11/26/2019Berenberg BankLower Price TargetBuyGBX 3,250 ➝ GBX 2,900
i
11/21/2019Deutsche Bank AktiengesellschaftDowngradeHoldGBX 2,800 ➝ GBX 2,200
i
11/21/2019HSBCLower Price TargetBuyGBX 3,400 ➝ GBX 3,300
i
11/21/2019Royal Bank of CanadaLower Price TargetSector PerformerGBX 2,500 ➝ GBX 2,200
i
11/20/2019Jefferies Financial GroupReiterated RatingHoldGBX 2,400
i
11/4/2019JPMorgan Chase & Co.Lower Price TargetOverweightGBX 2,740 ➝ GBX 2,400
i
9/24/2019Liberum CapitalInitiated CoverageBuyGBX 2,825
i
9/9/2019CitigroupReiterated RatingNeutral
i
8/15/2019Shore CapitalReiterated RatingBuy
i
8/12/2019Berenberg BankLower Price TargetBuyGBX 3,900 ➝ GBX 3,250
i
7/24/2019Deutsche Bank AktiengesellschaftLower Price TargetBuyGBX 2,900 ➝ GBX 2,800
i
7/23/2019Shore CapitalReiterated RatingBuy
i
7/18/2019Deutsche Bank AktiengesellschaftUpgradeBuyGBX 2,800 ➝ GBX 2,900
i
7/17/2019Royal Bank of CanadaReiterated RatingOutperform
i
7/12/2019Shore CapitalInitiated CoverageBuyGBX 2,900
i
7/12/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
i
7/9/2019Royal Bank of CanadaLower Price TargetOutperformGBX 3,800 ➝ GBX 3,400
i
7/5/2019Morgan StanleyLower Price TargetOverweightGBX 4,000 ➝ GBX 3,400
i
7/4/2019Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 2,800
i
6/28/2019HSBCReiterated RatingBuy
i
6/17/2019Numis SecuritiesReiterated RatingBuyGBX 3,600
i
6/13/2019Morgan StanleyReiterated RatingOverweightGBX 4,000
i
6/12/2019HSBCReiterated RatingBuyGBX 3,400
i
6/4/2019Berenberg BankReiterated RatingBuyGBX 3,900
i
5/24/2019Numis SecuritiesReiterated RatingBuyGBX 3,600
i
5/14/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
i
5/7/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
i
4/15/2019Royal Bank of CanadaBoost Price TargetOutperformGBX 3,500 ➝ GBX 3,800
i
4/9/2019Jefferies Financial GroupDowngradeHoldGBX 4,300 ➝ GBX 3,100
i
4/2/2019Berenberg BankReiterated RatingBuyGBX 3,900
i
3/28/2019Royal Bank of CanadaBoost Price TargetOutperformGBX 3,400 ➝ GBX 3,500
i
3/27/2019Deutsche Bank AktiengesellschaftReiterated RatingHold
i
3/26/2019Shore CapitalReiterated RatingUnder Review
i
2/28/2019Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 2,800
i
1/29/2019Berenberg BankLower Price TargetBuyGBX 4,250 ➝ GBX 3,900
i
1/25/2019Royal Bank of CanadaLower Price TargetOutperformGBX 3,600 ➝ GBX 3,400
i
1/25/2019Deutsche Bank AktiengesellschaftBoost Price TargetHoldGBX 2,700 ➝ GBX 2,800
i
12/13/2018Deutsche Bank AktiengesellschaftLower Price TargetHoldGBX 3,000 ➝ GBX 2,600
i
12/10/2018Berenberg BankReiterated RatingBuyGBX 4,250
i
12/4/2018Deutsche Bank AktiengesellschaftReiterated RatingHold
i
10/17/2018Deutsche Bank AktiengesellschaftInitiated CoverageHoldGBX 3,000
i
10/5/2018Berenberg BankBoost Price TargetBuyGBX 3,350 ➝ GBX 4,250
i
9/12/2018Morgan StanleyReiterated RatingOverweightGBX 4,200
i
8/6/2018Jefferies Financial GroupBoost Price TargetBuyGBX 4,000 ➝ GBX 4,300
i
7/24/2018Shore CapitalReiterated RatingHold
i
6/22/2018Jefferies Financial GroupBoost Price TargetBuyGBX 3,000 ➝ GBX 4,000
i
5/22/2018Berenberg BankReiterated RatingBuyGBX 3,350
i
5/17/2018Shore CapitalReiterated RatingHold
i
3/28/2018Shore CapitalReiterated RatingHold
i
3/19/2018Berenberg BankBoost Price TargetBuyGBX 2,850 ➝ GBX 3,350
i
3/19/2018Royal Bank of CanadaUpgradeOutperformGBX 2,350 ➝ GBX 3,300
i
3/13/2018Morgan StanleyReiterated RatingOverweightGBX 3,100
i
3/13/2018Shore CapitalReiterated RatingHold
i
1/24/2018Shore CapitalReiterated RatingHold
i
1/19/2018Jefferies Financial GroupInitiated CoverageBuyGBX 3,000
i
12/5/2017InvestecReiterated RatingBuyGBX 2,330
i
12/5/2017Shore CapitalReiterated RatingHold
i
11/20/2017Berenberg BankReiterated RatingBuyGBX 2,400
i
11/9/2017Royal Bank of CanadaReiterated RatingSector PerformerGBX 2,000
i
11/7/2017Shore CapitalReiterated RatingHold
i
11/2/2017Royal Bank of CanadaDowngradeSector PerformerGBX 2,400 ➝ GBX 2,000
i
7/28/2017Shore CapitalReiterated RatingHold
i
7/28/2017Whitman HowardBoost Price TargetHoldGBX 1,700 ➝ GBX 2,100
i
7/28/2017Berenberg BankBoost Price TargetBuyGBX 1,850 ➝ GBX 2,400
i
7/26/2017Royal Bank of CanadaBoost Price TargetOutperformGBX 1,950 ➝ GBX 2,400
i
7/20/2017Whitman HowardReiterated RatingHoldGBX 1,700
i
7/7/2017Royal Bank of CanadaReiterated RatingOutperformGBX 1,950
i
5/15/2017Whitman HowardBoost Price TargetHoldGBX 1,250 ➝ GBX 1,700
i
5/15/2017Shore CapitalReiterated RatingHold
i
4/20/2017Berenberg BankBoost Price TargetBuyGBX 1,450 ➝ GBX 1,700
i
3/24/2017Royal Bank of CanadaReiterated RatingOutperformGBX 1,700
i
3/21/2017InvestecReiterated RatingBuyGBX 1,675
i
3/21/2017Shore CapitalReiterated RatingBuy
i
3/17/2017Whitman HowardReiterated RatingHoldGBX 1,250
i
2/22/2017Royal Bank of CanadaInitiated CoverageOutperformGBX 1,700
i
2/22/2017Berenberg BankBoost Price TargetBuyGBX 1,325 ➝ GBX 1,450
i
2/9/2017Berenberg BankReiterated RatingBuyGBX 1,325
i
1/26/2017Berenberg BankBoost Price TargetBuyGBX 1,200 ➝ GBX 1,325
i
1/24/2017InvestecBoost Price TargetBuyGBX 1,140 ➝ GBX 1,300
i
1/24/2017Shore CapitalReiterated RatingBuy
i
1/24/2017Whitman HowardReiterated RatingHoldGBX 1,080
i
12/15/2016Berenberg BankReiterated RatingBuyGBX 1,200
i
12/14/2016Whitman HowardReiterated RatingHoldGBX 1,080
i
11/11/2016Berenberg BankBoost Price TargetBuyGBX 980 ➝ GBX 1,200
i
11/7/2016InvestecBoost Price TargetBuyGBX 915 ➝ GBX 1,140
i
8/1/2016Berenberg BankBoost Price TargetBuyGBX 810 ➝ GBX 980
i
7/26/2016InvestecBoost Price TargetBuyGBX 840 ➝ GBX 915
i
6/9/2016Berenberg BankUpgradeBuyGBX 600 ➝ GBX 810
i
5/19/2016Shore CapitalReiterated RatingHold
i
4/19/2016Berenberg BankReiterated RatingHoldGBX 600
i
3/18/2016Berenberg BankBoost Price TargetHoldGBX 570 ➝ GBX 600
i
3/14/2016Shore CapitalReiterated RatingHold
i
3/14/2016InvestecReiterated RatingBuyGBX 740
i
2/26/2016Berenberg BankInitiated CoverageHoldGBX 570
i
1/25/2016Shore CapitalReiterated RatingHold
i
1/25/2016InvestecBoost Price TargetBuyGBX 700 ➝ GBX 740
i
1/19/2016InvestecBoost Price TargetBuyGBX 472 ➝ GBX 700
i
(Data available from 1/15/2016 forward)
Fevertree Drinks Plc (FEVR.L) logo
Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, aromatic tonic water, Clementine tonic water, citrus tonic water lemon tonic water, ginger beer, ginger ale, smoky ginger ale, spiced orange ginger ale, Madagascan cola, Sicilian lemonade, lemonade, and spring soda water. It sells its products under Fever-Tree brand name to bars and restaurants. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks Plc in October 2014. Fevertree Drinks Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: GBX 2,334
2,304
2,394

50 Day Range

MA: GBX 2,410.50
2,222
2,550.39

52 Week Range

Now: GBX 2,334
888.40
2,587

Volume

190,940 shs

Average Volume

201,257 shs

Market Capitalization

£2.72 billion

P/E Ratio

57.07

Dividend Yield

0.63%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Fevertree Drinks Plc (FEVR.L)?

The following sell-side analysts have issued reports on Fevertree Drinks Plc (FEVR.L) in the last year: Barclays PLC, Berenberg Bank, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Liberum Capital, Morgan Stanley, Royal Bank of Canada, and The Goldman Sachs Group, Inc..

What is the current price target for Fevertree Drinks Plc (FEVR.L)?

10 Wall Street analysts have set twelve-month price targets for Fevertree Drinks Plc (FEVR.L) in the last year. Their average twelve-month price target is GBX 2,131, suggesting a possible downside of 8.9%. Liberum Capital has the highest price target set, predicting FEVR will reach GBX 2,570 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of GBX 1,440 for Fevertree Drinks Plc (FEVR.L) in the next year.

What is the current consensus analyst rating for Fevertree Drinks Plc (FEVR.L)?

Fevertree Drinks Plc (FEVR.L) currently has 2 sell ratings, 5 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in FEVR, but not buy more shares or sell existing shares.

What other companies compete with Fevertree Drinks Plc (FEVR.L)?

Other companies that are similar to Fevertree Drinks Plc (FEVR.L) include Coca-Cola HBC AG (CCH.L), Britvic plc (BVIC.L), Cott, Lassonde Industries, A.G. BARR p.l.c. (BAG.L), Nichols plc (NICL.L), Coca-Cola European Partners plc (CCEP.L), The Alkaline Water, Global Gardens Group Inc. (VGM.V), Arca Continental, Britvic, Coca-Cola Amatil Limited (CCL.AX), Coca-Cola FEMSA, DNA Brands and Eneco Refresh Limited (ERG.AX).

How do I contact Fevertree Drinks Plc (FEVR.L)'s investor relations team?

Fevertree Drinks Plc (FEVR.L)'s physical mailing address is Kildare HSE, 3 Dorset Rise, LONDON, EC4Y 8EN, United Kingdom. The company's listed phone number is +44-20-73494922. The official website for Fevertree Drinks Plc (FEVR.L) is www.fever-tree.com.